Across TCGA pan-cancer cohorts, HNRNPA1P18 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated HNRNPA1P18 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher HNRNPA1P18 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPA1P18 expression acts as an unfavorable survival marker, although some lineages such as LUSC and SKCM show a favorable association.
UVM, KIRC, and LUSC are the cancer types where HNRNPA1P18 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.